The risk of cardiovascular disease following breast cancer by Framingham risk score

[1]  H. Verkooijen,et al.  Risk of death from cardiovascular disease following breast cancer: a systematic review , 2017, Breast Cancer Research and Treatment.

[2]  S. Darby,et al.  Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977–2005 , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  Alan D. Lopez,et al.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.

[4]  P. Douglas,et al.  Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Horwitz,et al.  Causes of death among cancer patients , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  B. Khandheria,et al.  Risk factors of trastuzumab-induced cardiotoxicity in breast cancer , 2016, Medicine.

[7]  N. Weintraub,et al.  Novel concepts in radiation-induced cardiovascular disease , 2016, World journal of cardiology.

[8]  M. McCullough,et al.  Pre- and postdiagnostic diet in relation to mortality among breast cancer survivors in the CPS-II Nutrition Cohort , 2016, Cancer Causes & Control.

[9]  A. Blaes,et al.  Shared Risk Factors in Cardiovascular Disease and Cancer , 2016, Circulation.

[10]  A. Neugut,et al.  Cardiovascular Disease Mortality Among Breast Cancer Survivors , 2016, Epidemiology.

[11]  Ramachandran S Vasan,et al.  Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. , 2015, International journal of epidemiology.

[12]  Gillian D Sanders,et al.  Benefits and Harms of Breast Cancer Screening: A Systematic Review. , 2015, JAMA.

[13]  P. Vejpongsa,et al.  Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. , 2014, Journal of the American College of Cardiology.

[14]  Behnam Dalfardi,et al.  Chemotherapy-Induced Cardiomyopathy in Breast Cancer Patients , 2014, Research in cardiovascular medicine.

[15]  J. Sorkin,et al.  Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk , 2014, Cancer medicine.

[16]  EBCTCG (Early Breast Cancer Trialists' Collaborati.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.

[17]  S. Johnston,et al.  Pneumonitis and pulmonary fibrosis associated with breast cancer treatments , 2014, Breast Cancer Research and Treatment.

[18]  G. Hortobagyi,et al.  Trastuzumab-related cardiotoxicity among older patients with breast cancer. , 2013, Journal of Clinical Oncology.

[19]  W. Hundley,et al.  Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance , 2013, Journal of Cardiovascular Magnetic Resonance.

[20]  L. Moja,et al.  Trastuzumab containing regimens for early breast cancer. , 2012, The Cochrane database of systematic reviews.

[21]  K. Hemminki,et al.  Death causes in breast cancer patients. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  Salvatore Panico,et al.  Validity of a short questionnaire to assess physical activity in 10 European countries , 2011, European Journal of Epidemiology.

[23]  K. Czene,et al.  Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  P. Hall,et al.  Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[26]  P. Hall,et al.  A Dose-response Relationship for the Incidence of Radiation-related Heart Disease , 2010 .

[27]  D. Grobbee,et al.  Cohort profile: the EPIC-NL study. , 2010, International journal of epidemiology.

[28]  V. Cornelius,et al.  Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials , 2010, BMC Cancer.

[29]  E. Yeh,et al.  Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. , 2009, Journal of the American College of Cardiology.

[30]  W. Willett,et al.  Body Mass Index Before and After Breast Cancer Diagnosis: Associations with All-Cause, Breast Cancer, and Cardiovascular Disease Mortality , 2009, Cancer Epidemiology Biomarkers & Prevention.

[31]  J. Boer,et al.  Validity of coronary heart diseases and heart failure based on hospital discharge and mortality data in the Netherlands using the cardiovascular registry Maastricht cohort study , 2009, European Journal of Epidemiology.

[32]  J. Ingle,et al.  Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. , 2008, Journal of the National Cancer Institute.

[33]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[34]  G. Hortobagyi,et al.  Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  J. Goodwin,et al.  Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  H. Bartelink,et al.  Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. , 2007, Journal of the National Cancer Institute.

[37]  J. Cuzick,et al.  Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study , 2007, BMC Cancer.

[38]  J. Klijn,et al.  Decreased risk of stroke among 10-year survivors of breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  A Rogier T Donders,et al.  Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. , 2006, Journal of clinical epidemiology.

[40]  J. Klijn,et al.  Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. , 2006, International journal of radiation oncology, biology, physics.

[41]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[42]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[43]  A. Neugut,et al.  Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  R. Peto,et al.  Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. , 2005, The Lancet. Oncology.

[45]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[46]  L. Holmberg,et al.  Increased incidence of stroke in women with breast cancer. , 2005, European journal of cancer.

[47]  S. Devesa,et al.  Probabilities of death from breast cancer and other causes among female breast cancer patients. , 2004, Journal of the National Cancer Institute.

[48]  E. Riboli,et al.  Diet and cancer — the European Prospective Investigation into Cancer and Nutrition , 2004, Nature Reviews Cancer.

[49]  Jo Mitchell,et al.  Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study , 2003, Public Health Nutrition.

[50]  F. Clavel-Chapelon,et al.  Physical activity of subjects aged 50–64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2002, Public Health Nutrition.

[51]  M. Schulze,et al.  The effect of differences in measurement procedure on the comparability of blood pressure estimates in multi-centre studies , 2002, Blood pressure monitoring.

[52]  Ennis,et al.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.

[53]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[54]  Bueno de Mesquita Hb,et al.  Monitoring van Risicofactoren en Gezondheid in Nederland (MORGEN-project): Doelstellingen en werkwijze , 1994 .

[55]  B. Stricker,et al.  Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. , 1992, Journal of epidemiology and community health.

[56]  B. Haffty.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials: EBCTCG (Early Breast Cancer Trialists' Collaborative Group) () Lancet 383:2127-2135, 2014§ , 2014 .

[57]  E. Riboli,et al.  Prospect-EPIC Utrecht: Study design and characteristics of the cohort population , 2004, European Journal of Epidemiology.

[58]  D Kromhout,et al.  The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. , 1997, International journal of epidemiology.

[59]  D Kromhout,et al.  The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients. , 1997, International journal of epidemiology.

[60]  D.,et al.  Regression Models and Life-Tables , 2022 .